Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Receivables (2016 - 2026)

Iradimed has reported Change in Receivables over the past 14 years, most recently at -$212000.0 for Q1 2026.

  • Quarterly Change in Receivables fell 109.93% to -$212000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $680000.0 through Mar 2026, up 273.77% year-over-year, with the annual reading at $3.0 million for FY2025, 271.79% up from the prior year.
  • Change in Receivables was -$212000.0 for Q1 2026 at Iradimed, down from -$191434.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $2.9 million in Q3 2025 and troughed at -$1.8 million in Q2 2025.
  • The 5-year median for Change in Receivables is $188885.0 (2024), against an average of $497163.4.
  • Year-over-year, Change in Receivables skyrocketed 15386.55% in 2022 and then tumbled 213.03% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $2.7 million in 2022, then plummeted by 118.68% to -$498857.0 in 2023, then soared by 137.86% to $188885.0 in 2024, then tumbled by 201.35% to -$191434.0 in 2025, then decreased by 10.74% to -$212000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Change in Receivables are -$212000.0 (Q1 2026), -$191434.0 (Q4 2025), and $2.9 million (Q3 2025).